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ABSTRACT
Purpose: Maternal micronutrient deficiencies occurring during periconceptional, pregnancy, and
postpartum periods are a leading cause of adverse pregnancy outcomes globally. The Dietary
Reference Intakes (DRIs) are a set of reference values used to assess and guide nutrient intakes of
healthy individuals. However, the current DRIs for pregnancy and lactation may be limited in their
methods and included populations. The present study analyzed the current DRIs for their inclusion of
pregnant women and geographic representativeness. Methods: Meta-research methods were
applied to the DRI report for vitamins B6, B12, folate, and choline in four steps: search, screening,
full-text data extraction, and data analysis. For each target micronutrient, sections that contributed
data to setting the average requirement were focused on, “Selection of Indicators for Estimating the
Requirement,” “Findings by Life Stage and Gender Group,” and “Tolerable Upper Intake Limit” for
adults, pregnancy, and lactation sub-sections. Screening involved reviewing the reference list to
determine whether a reference directly contributed to setting the DRI. Full-text data extraction of
primary data was conducted in areas of: 1) administrative information; 2) study methods; 3) human
population characteristics; and 4) non-human subjects. Descriptive analyses were performed to
describe the inclusion of women, pregnant women, geographic patterns, and demographic diversity.
Results: For Vitamin B12, 100% of indicator studies and 71% of life stages studies included women,
with a total of 3,246 women participants. However, none of the indicator studies and 15% of life
stages studies included pregnant women, with a total of 556 pregnant women participants. None of
the indicator studies and 8% of life stages studies reported health measurements specific to women,
pregnancy, or lactation. Geographically, 54% of studies were conducted in the United States, and
18% took place in low-and middle-income countries. Data analysis is ongoing for the remaining
micronutrients. Conclusions: Preliminary findings indicate that the body of evidence informing the
current DRIs are limited in their inclusion of women and pregnant women. Numerous adverse
pregnancy and birth outcomes are preventable through optimal maternal nutrition. Therefore, it is
critical to ensure that the DRIs are suitable for their intended population. Despite their original intent
for use in North America, the DRIs are widely adopted globally. Thus, geographic representation of
the studies underlying the DRIs have implications for generalizability.

METHODS CONTINUED
Figure A: Meta-analysis workflow

RESULTS CONTINUED
Figure C: Characterization of Included Study Population

• While nearly four in five studies
included women, less than one in five
studies that form the basis for the
current DRI for vitamins B12, B6,
Folate, and Choline include pregnant
and lactating people.
• We found that for Vitamin B12 and
Choline there is not a single study
including pregnant or lactating
people that informed the selection of
indicators or for establishing the
upper level (UL).
• For Choline, there is not a single
study including pregnant or lactating
people that informed the selection of
indicators, life stages, or for
establishing the upper level (UL).

BACKGROUND
• Women and pregnant people are historically underrepresented in
medical research. Over 90% of clinically approved drugs still lack
information on safety, efficacy, and pharmacokinetics in pregnancy.1
• The Dietary Reference Intakes (DRIs), developed at the Institute of
Medicine, are a general term for a set of reference values used to
assess and guide nutrient intakes of healthy individuals.2
• DRIs are used to guide global nutrition policy, diet assessments, and
pregnancy vitamin and mineral supplement recommendation levels.
• Maternal micronutrient deficiencies occurring during
periconceptional, pregnancy, and postpartum periods are a leading
cause of adverse pregnancy outcomes globally.3
• One-carbon metabolism micronutrients, including folate, choline,
vitamin B6, and B12, are essential during pregnancy; deficiencies in
these nutrients are associated with adverse outcomes including
maternal preeclampsia and neural tube defects in the offspring.4
• We aimed at systematically investigating the body of evidence that
informed the DRI values in terms of:
• The inclusion of pregnant people and women of
reproductive age, and
• The geographic representation of these studies

3. Data Abstraction
• Full-text data extraction of primary data from each study was performed
in areas: 1) administrative information and study identification; 2) study
methods; 3) human population characteristics; and 4) non-human
subjects.
4. Data Analysis
• Descriptive analyses were performed to describe the inclusion of women,
pregnant women, women of reproductive age, geographic patterns, and
whether health outcomes specific to women/pregnancy/lactation were
included.
• For all characteristics analyzed, we focused on collecting data for the
number and proportion of studies. Total sample size of women was also
calculated.

RESULTS

Figure B: Number of research studies by country, proportion occurring in each
World Health Organization region, & proportion occurring in countries by their
World Bank Income Group

• The highest % of studies that included pregnant or lactating
people were observed for folate, nearly double that of B12.
• No studies for selection of indicators or for establishing the
upper level (UL) reported specific health outcomes for B12 or
Choline.

DISCUSSION & CONCLUSION
1. Similar to their historical exclusion in medical research, we found that pregnant and lactating people have been
excluded from clinical nutrition research that informs the DRIs for Vitamins B6, B12, Folate, and Choline, despite the
importance of these micronutrients during and after pregnancy for optimal health. (Figure C)
2. The percent of studies reporting health outcomes specific to women/pregnancy/lactation, such as milk volume or
low birth weight, varied significantly between the micronutrients analyzed. (Figure D)
• No studies informing the selection of indicators or for establishing the upper level (UL) reported specific health
outcomes for B12 or Choline, which is problematic as optimal biomarkers of micronutrient status may vary by
reproductive state.

METHODS
• Meta-research methods were applied to the DRI report for Vitamin
B6, Vitamin B12, Folate, and Choline in four steps: search, screening,
full-text data extraction, and data analysis.
1. Search
• All studies which potentially contributed to the 1998 DRI report for
B6, B12, folate, and Choline were searched.
2. Screening
• A panel of five experts reviewed the reference list to determine
whether a reference directly contributed to setting the DRI for that
micronutrient.
• 224 human or animal primary studies, and 206 only human primary
studies which were considered as contributing to the DRIs were
ultimately included for Vitamins B12, B6, Folate, and Choline.

Figure D: Percent of Studies Reporting Health Outcomes Specific
to Women/ Pregnancy/ Lactation: B12, Folate, Choline and B6

3. The nutrient reference values were originally intended for use in North America, however, the DRIs are widely
adopted and used globally, and so global reference values require underlying high-quality data representative of the
global population, rather than primarily the US, the UK, and high-income countries, which was the case for one-the
carbon-metabolism micronutrients analyzed.

• Less than 2% of the studies included in the DRIs for one-carbon metabolism
micronutrients were conducted in Lower-Middle Income countries. No studies
were conducted in Low-Income countries.

The current dietary reference intake values, which inform supplement formulations and nutrition policy in
the US and globally, do not adequately include pregnant people for one-carbon metabolism micronutrients
that are critical for a healthy pregnancy and birth outcomes. The DRIs demonstrate low geographic
representativeness and may not be applicable to varying global population’s needs.
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